BioSpace.com
Visit BioSpace.comMedical Device and Diagnostics Channel
 Biotechnology and Pharmaceutical Headlines
2010/03/08  13:47  
Sundia MediTech Authorized ISO 9001:2008 Quality System Certificate

2010/01/20  11:35  
NEC's Facial Recognition Technology Achieves First Place in the Still-Face Dataset of the NIST Multiple Biometric Grand Challenge

2010/01/19  15:18  
Fujitsu Launches SaaS Solution for Clinical Drug Trials

2010/01/14  16:22  
Eisai Submits Application for Additional Indication of Anti-arrhythmic Agent Tambocor(R) Tablets for Tachyarrhythmia in Paediatric Patients in Japan

2010/01/13  16:51  
Sysmex Announces Establishment of Overseas Subsidiary in Spain to Expand Life Science Business

2009/12/24  16:36  
Submission of a New Drug Application for Pancreatic Enzyme Replacement Therapy Agent SA-001 in Japan

2009/12/10  09:36  
Xing Lin Medical Information Technology Announces Positioning in Healthcare Information System Market in China

2009/12/03  18:14  
MHI's First Radiotherapy Machine for Overseas to Begin Treatment at Brussels University Hospital (UZ Brussel)

2009/12/01  15:08  
Eisai Launches New Oral Jelly Formulation of Aricept(R), World's First Oral Jelly for Alzheimer's Disease Treatment

2009/10/30  18:29  
Eisai and Quintiles Enter into a Strategic Collaboration to Develop Eisai's Anticancer Compounds

2009/10/30  16:15  
Global Phase III Study Results Show Eribulin Meets Primary Endpoint of Overall Survival

2009/10/26  17:36  
Eisai and TSD Japan Enter into a License and Joint Development Agreement of Denileukin Diftitox in Japan

2009/10/22  16:36  
MGH and NEC Start On-Site Evaluation of NEC Cancer Diagnosis Assistance System e-Pathologist at MGH

2009/10/16  11:51  
Eisai Opens Regional Office in Bahrain

2009/10/15  14:00  
Mitsibishi Corporation Announces Comprehensive Alliance with Sinopharm Group and Investment in Beijing Huahong

2009/09/30  11:56  
Abbott and Eisai Submit Application for Approval of Humira(R) for the Treatment of Crohn's Disease in Japan

2009/09/29  17:02  
Eisai and DNDi Enter Collaboration and License Agreement to Develop New Drug for Chagas Disease

2009/09/29  16:55  
Eisai Submits Application for Additional Indication of its Proton Pump Inhibitor PARIET(R) for Non-erosive GERD in Japan

2009/09/29  16:39  
KYORIN and Eisai Sign License Agreement for Development and Marketing of Uritos(R) Tablets in China, India, Sri Lanka and ASEAN Countries

2009/09/16  18:04  
Suprema Raises $36M in New Share Issue